Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection.

Source:http://linkedlifedata.com/resource/pubmed/id/2181031

Download in:

View as

General Info

PMID
2181031